危重先天性心脏病早期儿童住院费用研究
该研究基于犹他州1997至2012年活产婴儿中临床验证的危重先天性心脏病(CCHD)病例,追踪至10岁的住院费用。结果显示每名患儿至10岁平均费用为136 682美元,中位数为74 924美元,费用逐年上升且因缺陷类型而异, extrapolating至全美单出生队列至10岁住院费用约10亿美元。
要点
- CCHD患儿至10岁平均住院费用136 682美元,中位数74 924美元。
- 费用最高见于肺动脉闭锁伴室间隔缺损和左心发育不良综合征。
- 研究期间住院费用每年增加1.6%,全美单出生队列至10岁费用约10亿美元。
核心结论
- CCHD患儿整个童年期住院费用高昂且呈上升趋势。
- 修订后的费用估计有助于开展比较效果研究以提升患者和人群层面的医疗价值。
研究设计与样本
- 基于犹他州1997至2012年活产婴儿的纵向回顾性队列,纳入出生缺陷登记中临床验证的CCHD病例。
- 共1439例CCHD病例,对应803 509例活产(1.8/1000),链接住院出院摘要和生命记录追踪至10岁的住院天数和费用。
- 费用经通胀调整并按每年3%贴现计算现值,多变量模型识别相关因素并计算各缺陷类型的调整费用。
主要发现
- 每名受累儿童至10岁平均费用136 682美元,中位数74 924美元,因少数极高费用患儿导致均值高于中位数。
- 费用最高见于肺动脉闭锁伴室间隔缺损和左心发育不良综合征。
- 研究期间住院费用每年增加1.6%。
- 单个出生年份队列(约50 000例/年)至10岁估计支出11 902 899美元。
- extrapolating至美国人群,单个出生年份队列至10岁住院费用约10亿美元。
临床怎么用
- 临床医生应了解CCHD患儿长期住院费用高昂且逐年上升,在决策中考虑资源利用。
- 费用因缺陷类型差异显著,肺动脉闭锁伴室间隔缺损和左心发育不良综合征患儿需重点关注费用管理。
- 研究提供的费用估计可用于比较效果研究,辅助改善患者和人群层面的医疗价值。
局限性
- 研究仅基于犹他州数据, extrapolating至全美人群需谨慎。
- 费用估计仅涵盖住院费用,未包括门诊等其他医疗费用。
- 回顾性队列设计可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess longitudinal estimates of inpatient costs through early childhood in patients with critical congenital heart defects (CCHDs), for whom reliable estimates are scarce, using a population-based cohort of clinically validated CCHD cases. STUDY DESIGN: Longitudinal retrospective cohort of infants with CCHDs live born from 1997 to 2012 in Utah. Cases identified from birth defect registry data were linked to inpatient discharge abstracts and vital records to track inpatient days and costs through age 10 years. Costs were adjusted for inflation and discounted by 3% per year to generate present value estimates. Multivariable models identified infant and maternal factors potentially associated with higher resource utilization and were used to calculate adjusted costs by defect type. RESULTS: The final statewide cohort included 1439 CCHD cases among 803 509 livebirths (1.8/1000). The average cost per affected child through age 10 years was $136 682 with a median of $74 924 because of a small number of extremely high cost children; costs were highest for pulmonary atresia with ventricular septal defect and hypoplastic left heart syndrome. Inpatient costs increased by 1.6% per year during the study period. A single birth year cohort (~50 000 births/year) had estimated expenditures of $11 902 899 through age 10 years. Extrapolating to the US population, inpatient costs for a single birth year cohort through age 10 years were ~$1 billion. CONCLUSIONS: Inpatient costs for CCHDs throughout childhood are high and rising. These revised estimates will contribute to comparative effectiveness research aimed at improving the value of care on a patient and population level.
引用
- Pinto NM, Waitzman N, Nelson R, et al. Early Childhood Inpatient Costs of Critical Congenital Heart Disease. J Pediatr. 2018. PMID: 30268400. doi:10.1016/j.jpeds.2018.07.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。